These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 7081974

  • 1. Effect of clindamycin, erythromycin, lincomycin, and tetracycline on growth and extracellular lipase production by propionibacteria in vitro.
    Unkles SE, Gemmell CG.
    Antimicrob Agents Chemother; 1982 Jan; 21(1):39-43. PubMed ID: 7081974
    [Abstract] [Full Text] [Related]

  • 2. Resistance of propionibacteria to antibiotics used in the treatment of acne.
    Brown JM, Poston SM.
    J Med Microbiol; 1983 Aug; 16(3):271-80. PubMed ID: 6224016
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of lipase activity in antibiotic-resistant propionibacterium acnes strains.
    Gloor M, Wasik B, Becker A, Höffler U.
    Dermatology; 2002 Aug; 205(3):260-4. PubMed ID: 12399674
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of lipase production in Propionibacterium acnes by sub-minimal-inhibitory concentrations of tetracycline and erythromycin.
    Webster GF, McGinley KJ, Leyden JJ.
    Br J Dermatol; 1981 Apr; 104(4):453-7. PubMed ID: 6786318
    [No Abstract] [Full Text] [Related]

  • 5. In vitro activity of kaempferol isolated from the Impatiens balsamina alone and in combination with erythromycin or clindamycin against Propionibacterium acnes.
    Lim YH, Kim IH, Seo JJ.
    J Microbiol; 2007 Oct; 45(5):473-7. PubMed ID: 17978809
    [Abstract] [Full Text] [Related]

  • 6. Effects of subminimal inhibitory concentrations of erythromycin, tetracycline, clindamycin, and minocycline on the neutrophil chemotactic factor production in Propionibacterium acnes biotypes 1-5.
    Akamatsu H, Nishijima S, Takahashi M, Ushijima T, Asada Y.
    J Dermatol; 1991 May; 18(5):247-51. PubMed ID: 1834712
    [Abstract] [Full Text] [Related]

  • 7. Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne.
    Schafer F, Fich F, Lam M, Gárate C, Wozniak A, Garcia P.
    Int J Dermatol; 2013 Apr; 52(4):418-25. PubMed ID: 23432195
    [Abstract] [Full Text] [Related]

  • 8. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure.
    Eady EA, Cove JH, Holland KT, Cunliffe WJ.
    Br J Dermatol; 1989 Jul; 121(1):51-7. PubMed ID: 2527056
    [Abstract] [Full Text] [Related]

  • 9. Antibiotic sensitivity of comedonal Propionibacterium acnes.
    Guin JD, Huber DS, Gielerak PL.
    Acta Derm Venereol; 1979 Jul; 59(6):552-54. PubMed ID: 94223
    [Abstract] [Full Text] [Related]

  • 10. Antibiotic-resistant acne: lessons from Europe.
    Ross JI, Snelling AM, Carnegie E, Coates P, Cunliffe WJ, Bettoli V, Tosti G, Katsambas A, Galvan Peréz Del Pulgar JI, Rollman O, Török L, Eady EA, Cove JH.
    Br J Dermatol; 2003 Mar; 148(3):467-78. PubMed ID: 12653738
    [Abstract] [Full Text] [Related]

  • 11. Effects of pH on biomass, maximum specific growth rate and extracellular enzyme production by three species of cutaneous propionibacteria grown in continuous culture.
    Greenman J, Holland KT, Cunliffe WJ.
    J Gen Microbiol; 1983 May; 129(5):1301-7. PubMed ID: 6311940
    [Abstract] [Full Text] [Related]

  • 12. In Vitro activity of 6 antimicrobials against propionibacteria isolates from untreated acne papulopustulosa.
    Fluhr JW, Gloor M, Dietz P, Höffler U.
    Zentralbl Bakteriol; 1999 Feb; 289(1):53-61. PubMed ID: 10096167
    [Abstract] [Full Text] [Related]

  • 13. Antibiotic susceptibility testing of anaerobic bacteria by the standardized disc diffusion method with special reference to bacteroides fragilis.
    Dornbusch K, Nord CE, Olsson B.
    Scand J Infect Dis; 1975 Feb; 7(1):59-66. PubMed ID: 167431
    [Abstract] [Full Text] [Related]

  • 14. [In vitro sensitivity of Corynebacterium acnes (Propionibacterium acnes) to meclocycline, clindamycin, erythromycin and neomycin].
    Lucca L, Vittadini G.
    G Ital Chemioter; 1979 Feb; 26(1-2):203-6. PubMed ID: 554810
    [No Abstract] [Full Text] [Related]

  • 15. Effect of lipase activities of Propionibacterium granulosum and Propionibacterium acnes.
    Higaki S, Nakamura M, Kitagawa T, Morohashi M, Yamagishi T.
    Drugs Exp Clin Res; 2001 Feb; 27(5-6):161-4. PubMed ID: 11951573
    [Abstract] [Full Text] [Related]

  • 16. Suppression of polymorphonuclear leukocyte chemotactic factor production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracycline, ampicillin, minocycline, and erythromycin.
    Webster GF, Leyden JJ, McGinley KJ, McArthur WP.
    Antimicrob Agents Chemother; 1982 May; 21(5):770-2. PubMed ID: 7049078
    [Abstract] [Full Text] [Related]

  • 17. Comparative activity of the topical quinolone OPC-7251 against bacteria associated with acne vulgaris.
    Vogt K, Hermann J, Blume U, Gollnick H, Hahn H, Haustein UF, Orfanos CE.
    Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):943-5. PubMed ID: 1486893
    [Abstract] [Full Text] [Related]

  • 18. Nasal antibiotic-resistant Propionibacterium acnes carriage in acne vulgaris patients in Turkey.
    Ergin C, Ergin S, Kaleli I, Kaçar N, Sengül M, Erdoğan BS.
    J Dermatol; 2006 Dec; 33(12):899-901. PubMed ID: 17169100
    [No Abstract] [Full Text] [Related]

  • 19. A Myrtus communis extract enriched in myrtucummulones and ursolic acid reduces resistance of Propionibacterium acnes biofilms to antibiotics used in acne vulgaris.
    Feuillolay C, Pecastaings S, Le Gac C, Fiorini-Puybaret C, Luc J, Joulia P, Roques C.
    Phytomedicine; 2016 Mar 15; 23(3):307-15. PubMed ID: 26969384
    [Abstract] [Full Text] [Related]

  • 20. Toxic shock syndrome toxin-1 (TSST-1): influence of its production by subinhibitory antibiotic concentrations.
    Dickgiesser N, Wallach U.
    Infection; 1987 Mar 15; 15(5):351-3. PubMed ID: 3692606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.